Aspen Aerogels (ASPN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Q2 2026 revenue reached $49.8 million, up 32% quarter-over-quarter, driven by strong thermal barrier sales and deferred revenue recognition from a GM settlement, but down from $78.0 million year-over-year due to regulatory impacts on North American EV incentives.
PyroThin thermal barrier business saw 81% quarter-over-quarter growth to $29.5 million, with expanding European OEM awards, including Jaguar Land Rover.
Staged restart of the East Providence plant is underway after an April incident, with full capacity expected in H1 2027 and customer supply maintained.
Net loss for Q2 2026 was $23.3 million, including $8.9 million in property damage from the East Providence incident, offset by insurance receivable.
Ended Q2 with $153.4 million in cash and equivalents, maintaining strong liquidity and covenant headroom.
Financial highlights
Q2 gross profit was $3.3 million (7% margin), impacted by $5.3 million in incident-related costs; adjusted gross profit was $8.6 million (17% margin).
Adjusted EBITDA improved to negative $6.6 million from negative $12.7 million in Q1; Q2 net loss was $23.3 million, with adjusted net loss at $17.9 million.
Cash flow from operations for the first half of 2026 was $17.9 million.
Weighted average shares outstanding for Q2: 82.9 million.
Outlook and guidance
Q3 2026 revenue expected between $65 million and $80 million; adjusted EBITDA guidance is $7–$15 million, including $5–$10 million in incident-related add-backs.
European thermal barrier revenue outlook for 2026 raised to $20–$30 million, with 2027 targeted at $40–$60 million.
Energy industrial segment expected to maintain 20% growth in 2027, with a path to $200 million annual revenue.
FY 2026 capex expected below $10 million, excluding East Providence restoration.
Latest events from Aspen Aerogels
- Strong margin gains, new OEM launches, and DOE-backed expansion drive robust growth outlook.ASPN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20249 Jul 2026 - Record 2024 revenue, margin expansion, and capital-light strategy support resilient outlook.ASPN
Q4 20248 Jul 2026 - All proposals passed, including director elections and board declassification.ASPN
AGM 202619 May 2026 - Q1 2026 revenue dropped, but net loss improved and strong cash reserves support recovery.ASPN
Q1 20268 May 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and board structure.ASPN
Proxy filing27 Mar 2026 - Proxy covers director elections, auditor ratification, executive pay, and board declassification.ASPN
Proxy filing27 Mar 2026 - Annual meeting covers director elections, pay, auditor ratification, and board declassification.ASPN
Proxy Filing13 Mar 2026 - Cost discipline, European wins, and energy industrial growth support 2026 recovery.ASPN
Q4 202525 Feb 2026 - Record Q2 revenue and profitability drive raised 2024 outlook and margin expansion.ASPN
Q2 20242 Feb 2026